FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 84296

News▲ Bullish

CRISPR Market worth $6.12 billion by 2031

CRISPR Market worth $6.12 billion by 2031
EXHIBIT · mmx.prnewswire.com
KINDNews
DIRECTION▲ Bullish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

A forecast CRISPR market CAGR of 12% supports long-run gene-editing tool and therapy demand.

Gene-editing market growth forecast supports sector
CATALYST TO WATCH

Clinical approvals and trial data

MAIN RISK

Forecast is vendor-sponsored and unverified

FULL DISPATCH

DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48 billion in 2026, at a CAGR of 12.0% during the forecast period. Browse 388 market data Tables and 53 Figures spread through 319...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · PRIMARY2026-10-16 14:30 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

→CORRELATIONshares Healthcare
Buyers reward strong fundamentals as M&A accelerates
2026-10-16 14:27 UTC
→CORRELATIONshares Healthcare, XBI
Sickle cell gene therapies offer new hope, but access remains a major challenge
2026-10-16 14:43 UTC
→CORRELATIONshares Healthcare
City Therapeutics allocated no shares to half of IPO orders
2026-10-16 14:48 UTC
←CORRELATIONshares Healthcare
Nabsys Launches RepX™ for Repeat Expansion Analysis Ahead of ASHG 2026
2026-10-16 12:00 UTC

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.